Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

KRX:007570 Revenue

Ilyang Pharmaceutical Co.,Ltd had revenue of 68.83B KRW in the quarter ending September 30, 2025, a decrease of -0.38%. This brings the company's revenue in the last twelve months to 276.09B, up 47.93% year-over-year. In the year 2024, Ilyang Pharmaceutical Co.,Ltd had annual revenue of 268.86B with 0.82% growth.

• Revenue (ttm): 276.09B
• Revenue Growth: +47.93%
• P/S Ratio: 0.85
• Revenue / Employee: 414.55M
• Employees: 666
• Market Cap: 233.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	268.86B	2.19B	0.82%
Dec 31, 2023	266.67B	18.90B	7.63%
Dec 31, 2022	247.77B	5.26B	2.17%
Dec 31, 2021	242.51B	-100.82B	-29.36%
Dec 31, 2020	343.33B	18.76B	5.78%